ELISA for a complexed antigen with a monoclonal antibody blocking reaction with the free antigen - Assay-specific for complexed prostate- specific antigen

Journal of Immunological Methods

Volumn 234, Issue 1-2, 2000, Pages 99-106

  Matsumoto, Kyoichi ^a,b   Konishi, Noboru ^a   Samori, Tomohiro ^b   Kimura, Emi ^b   Doi, Michiko ^b   Kato, Seiji ^b   Yuki, Yo Ichi ^c  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Research Division   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Complexed prostate specific antigen (c PSA); Enzyme linked immunoassay; Monoclonal antibodies; PSA 1 antichymotrypsin complex (PSA ACT); Tumor marker

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN SPECIFICITY; ARTICLE; COMPLEX FORMATION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

ALPHA 1-ANTICHYMOTRYPSIN; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LINEAR MODELS; MALE; PROSTATE-SPECIFIC ANTIGEN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0033980554     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(99)00209-4     Document Type: Article

References (30)

1. Borchert G.H., Melegos D.N., Tomlinson G., Giai M., Roagna R., Ponzone R., Sgro L., Diamandis E.P. Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases. Br. J. Cancer. 76:1997;1087.
2. Catalona W.J., Smith D.S. Comparison of different serum prostate specific antigen measures for early prostate cancer detection. Cancer. 74:1994;1516.
3. Catalona W.J., Smith D.S., Ratliff T.L., Dodds K.M., Coplen D.E., Yuan J.J., Petros J.A., Andriole G.L. Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 324:1991;1156.
4. Chan D.W., Bruzek D.J., Oestlering J.E., Rock R.C., Walsh P.C. Prostate-specific antigen as a marker for prostate cancer: a monoclonal and a polyclonal immunoassay compared. Clin. Chem. 33:1987;1916.
5. Christensson A., Laurell C., Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine protease inhibitors. Eur. J. Biochem. 194:1990;755.
6. 1-antichymotrypsin as an indicator of prostate cancer. J. Urol. 150:1993;100.
7. Espana F., Sanchez-Cuenca J., Vera C.D., Estelles A., Gilabert J. A quantitative ELISA for the measurement of complexes of prostate specific antigen with protein C inhibitor when using a purified standard. J. Lab. Clin. Med. 122:1993;711.
8. Ferguson R.A., Yu H., Kalyvas M., Zammit S., Diamandis E.P. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the ImmuliteR immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clin. Chem. 55:1996;675.
9. Graves, H.C.B., Wehner, N., Stamey, T., 1990. Comparison of a polyclonal and monoclonal immunoassay for PSA: need for an international antigen standard. J. Urol.
10. Horton G.L., Bahnson R.R., Daft M., Chan K.M., Catarona W.J., Ladenson J.H. Differences in values obtained with 2 assays of prostate specific antigen. J. Urol. 139:1988;762.
11. Hudson M.A., Bahnson R.R., Catalona W.J. Clinical use of prostate specific antigen in patients with prostate cancer. J. Urol. 142:1989;1011.
12. Kuriyama M., Ueno K., Uno H., Kawada Y., Akimoto S., Noda M., Nasu Y., Tsushima T., Ohmori H., Sakai H., Saito Y., Meguro N., Usami M., Kotake T., Suzuki Y., Arai Y., Shimazaki J. Clinical evaluation of serum prostate-specific antigen-alpha1-antichymotrypsin complex values in diagnosis of prostate cancer: a cooperative study. Int. J. Urol. 5:1998;48.
13. Levesque M., Yu H., Diamandis E.P. Prostate-specific antigen expression by various tumors. J. Clin. Lab. Anal. 9:1995;123.
14. Lilja H. A kallilrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J. Clin. Invest. 76:1985;1899.
15. 1-antichymotrypsin. Clin. Chem. 37:1991;1618.
16. Lundwall A. Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem. Biophys. Res. Commun. 161:1989;1151.
17. Matsumoto K., Konishi N., Hiasa Y., Kimura E., Takahashi Y., Sinohara K., Samori T. A highly sensitive enzyme-linked immunoassay for serum free prostate specific antigen (f-PSA). Clin. Chim. Acta. 281:1999;57.
18. Nilsson O., Peter A., Andersson I., Nilsson K., Grundstrom B., Karlsson B. Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA. Br. J. Cancer. 75:1997;789.
19. 1-antichymotrypsin complex. Clin. Chem. 41:1995;1480.
20. Ruckle H.C., Klee G.G., Oesterling J.E. Prostate specific antigen: concepts for staging prostate cancer and monitoring response to therapy. Mayo Clin. Proc. 69:1981;69.
21. Rusciano D., Berardi A., Ceccarini C., Terrana B. Concomitant purification of prostatic carcinoma tumor markers from human seminal fluid under nondenaturing conditions. Clin. Chem. 34:1988;2528.
22. Setoguchi C., Matsumoto K., Samori T., Kimura E., Harukaze S. Enzyme-linked immunosorbent assay for serum prostate specific antigen (PSA) using monoclonal antibodies. Jpn. J. Clin. Pathol. 46:1998;79.
23. Stamey T.A., Yang N., Hay A.R., McNeal J.E., Freiha F.S., Redwine E. Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med. 317:1987;909.
24. 1-antichymotrypsin is the major form of prostate-specific antigen serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res. 51:1991;222.
25. Wang M., Valenzuela L., Murphy G., Chu T. Purification of a human prostate specific antigen. Invest. Urol. 17:1979;159.
26. Wang M.C., Papsidero M.C., Kuriyama M., Valenzuela L.A., Murphy G.P., Chu T.M. Prostate antigen: a new potential marker for prostate cancer. Prostate. 2:1981;89.
27. Watt K.W.K., Lee P.-J., M'timkulu T., Chan W.-P., Loor R. Human prostate specific antigen: structural and functional similarity with serine protease. Proc. Natl. Acad. Sci. U. S. A. 83:1986;3166.
28. 1-antichymotrypsin complex for the screening and management of prostate cancer. J. Clin. Lab. Anal. 12:1998;32.
29. Yu H., Diamandis E.P., Sutherland D.J.A. Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin. Biochem. 27:1994;75.
30. Yu H., Giai M., Diamandis E.P., Katsaros D., Sutherland D.J.A., Levesque M.A., Roagana R., Sismondi P. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res. 55:1995;2104.